LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION - Patent 3493814

(19)

(11)

EP 3 493 814 A1

(12)

(43)	Date of publication:
	12.06.2019 Bulletin 2019/24

(21)	Application number: 17837574.7

(22)	Date of filing: 01.08.2017

(51)

International Patent Classification (IPC):

A61K 31/66^(2006.01)

C07F 9/02^(2006.01)

(86)	International application number:
	PCT/US2017/044984

(87)	International publication number:
	WO 2018/026866 (08.02.2018 Gazette 2018/06)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	MA MD

(30)

Priority:

03.08.2016 US 201662370637 P

(71)	Applicant: Neuropore Therapies, Inc.
	San Diego, CA 92121 (US)

(72)	Inventors:
	WRASIDLO, Wolfgang San Diego CA 92121 (US) NATALA, Srinivasa, Reddy San Diego CA 92121 (US)

(74)	Representative: Mewburn Ellis LLP
	City Tower 40 Basinghall Street London EC2V 5DE London EC2V 5DE (GB)

(54)	LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION